Mr. Pyara Singh

Half a decade of experience as an entrepreneur renders Mr. Pyara Singh with a business acumen that’s second to none. Despite tasting unparalleled success the man is an epitome of humility and has his humanitarian spirit still intact.

Mr. Maneet Singh (Founder)
President and CEO

A fervent spirit that he is, Mr. Maneet Singh always wanted to contribute something worthwhile to the multifaceted realms of knowledge and innovation. His zest to perfect the understanding of all that he indulges in led him to acquire 15 years of rich experience in fields as diverse as Clinical Research, Medical KPO, Telecommunication, Data Management and Turn-key Project Consulting. Often addressed by the industry as ‘The Solution Person’, he is instrumental in tapping human potential to the fullest.

Bill Van Nostrand
Director of Business Development

Bill comes to ClinActis with over 40 years of Clinical and Pharmaceutical experience. Bill was one of the pioneers in the CRO industry as a founder of the largest late stage CRO, In Vivo, Inc. that he grew to over 300 people and offices on three continents.After selling In Vivo, he became President of the Clinical Division of Dendrite International, helping launch their global EDC and Safety support helpdesk. Mr. Van Nostrand went on to lead the clinical division of FCG before becoming the Chief Business Officer for The Copernicus Group IRB. Most recently, Bill served as EVP and head of Business Development for WCCT Global, a leading Phase 1-4 CRO with one of the largest Clinical Pharmacology units in the U.S.

Ken Robinson
Member, Advisory Board

Ken is pioneer in Regulatory Submissions. Ken has helped establish and direct, writing groups at Sterling Winthrop, Sanofi, DuPont Merck, DuPont Pharmaceuticals and Bristol-Myers Squibb. Ken is trained in advanced writing, reviewing and presentation techniques to meet the needs of health agency reviewers.

Dr. Christian Tidona
Member, Advisory Board

Christian Tidona is a biotech entrepreneur, business angel, and managing director at the BioMed X Innovation Center in Heidelberg, Germany. He studied molecular biology and received his doctoral degree from the University of Heidelberg. Throughout his entire professional life his focus has always been to foster innovation at the interface between academia and industry. Christian is co-founder of the Health Axis Europe alliance between the European health innovation clusters in Leuven, Maastricht, Copenhagen, and Heidelberg. He is chairman of the Weizmann Young European Network (WYEN) and member of the International Board of the Weizmann Institute of Science in Israel. Christian is married and father of two children.

Dr. Elisabeth Hervier
Member, Advisory Board

A Paris based expert in International Regulatory Affairs and Biotechnologies, Dr Elisabeth Hervier has been associated with the Pharmaceutical industry for the past 45 years. She is presently a mentor to a number of pharmaceutical, consulting and service companies. Having been an avid entrepreneur and anchor to many pharmaceutical companies in France, she has served as the president of Zydus in France, Vice-President of CCIP-Paris, district-in charge of International Business & Paris development Agency, and consultant to many others like Ranbaxy.

Dr. Prithipal Singh
Member, Advisory Board

Dr Prithipal Singh, a medical pioneer, is the first Indian to take a Biomedical Company public on NASDAQ stock exchange in 1992. His last product was launched by President Bill Clinton at the White House. Holder of over 40 US patents and over 200 worldwide, this man currently serves on the Board of Directors of Abaxis, Inc. and has been the Vice President at Syntex Corporation, Executive Vice President of Idetec Corporation and the Vice President of Syva Corporation. He also founded ChemTrak Inc (funded by Sequoia Capital) among other companies.

Our Clients


Get in Touch